205 related articles for article (PubMed ID: 21425247)
21. Assessment of efficacy and safety of pandemic A/H1N1/2009 influenza vaccine in a group of health care workers.
Mascagni P; Vicenzi E; Kajaste-Rudnitski A; Pellicciotta G; Monti A; Cervi C; Vitalucci R; Toffoletto F
Med Lav; 2012; 103(3):220-9. PubMed ID: 22838300
[TBL] [Abstract][Full Text] [Related]
22. Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation.
Lagler H; Tobudic S; Ramharter M; Elandt K; Sperr WR; Redlberger-Fritz M; Popow-Kraupp T; Jäger U; Zielinski CC; Burgmann H
Vaccine; 2012 Nov; 30(48):6864-70. PubMed ID: 22989690
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
Roman F; Vaman T; Gerlach B; Markendorf A; Gillard P; Devaster JM
Vaccine; 2010 Feb; 28(7):1740-5. PubMed ID: 20034605
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.
Saad CG; Borba EF; Aikawa NE; Silva CA; Pereira RM; Calich AL; Moraes JC; Ribeiro AC; Viana VS; Pasoto SG; Carvalho JF; França IL; Guedes LK; Shinjo SK; Sampaio-Barros PD; Caleiro MT; Goncalves CR; Fuller R; Levy-Neto M; Timenetsky Mdo C; Precioso AR; Bonfa E
Ann Rheum Dis; 2011 Jun; 70(6):1068-73. PubMed ID: 21540203
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
Lu CY; Shao PL; Chang LY; Huang YC; Chiu CH; Hsieh YC; Lin TY; Huang LM
Vaccine; 2010 Aug; 28(36):5864-70. PubMed ID: 20600484
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
Wallin L; Quintilio W; Locatelli F; Cassel A; Silva MB; Skare TL
Acta Reumatol Port; 2009; 34(3):498-502. PubMed ID: 19820674
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients.
Aikawa NE; Trudes G; Campos LM; Pereira RM; Moraes JC; Ribeiro AC; Miraglia J; Timenetsky Mdo C; Bonfa E; Silva C
Lupus; 2013 Nov; 22(13):1394-8. PubMed ID: 24076765
[TBL] [Abstract][Full Text] [Related]
28. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM
Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406
[TBL] [Abstract][Full Text] [Related]
29. Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis.
Aikawa NE; Campos LM; Goldenstein-Schainberg C; Saad CG; Ribeiro AC; Bueno C; Precioso AR; Timenetsky Mdo C; Silva CA; Bonfá E
Scand J Rheumatol; 2013; 42(1):34-40. PubMed ID: 22992045
[TBL] [Abstract][Full Text] [Related]
30. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza.
Kung HC; Huang KC; Kao TM; Lee YC; Chang FY; Wang NC; Liu YC; Lee WS; Liu HJ; Chen CI; Chen CH; Huang LM; Hsieh SM
Vaccine; 2010 Oct; 28(45):7337-43. PubMed ID: 20817013
[TBL] [Abstract][Full Text] [Related]
31. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R
Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major.
Esposito S; D'Angelo E; Daleno C; Peia F; Scala A; Serra D; Mirra N; Galeone C; Principi N
Vaccine; 2010 Nov; 28(50):7825-8. PubMed ID: 20888873
[TBL] [Abstract][Full Text] [Related]
33. Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults.
Lopez P; Caicedo Y; Sierra A; Tilman S; Banzhoff A; Clemens R
J Infect Dis; 2011 Jun; 203(12):1719-28. PubMed ID: 21606530
[TBL] [Abstract][Full Text] [Related]
34. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
Cullen G; Bader C; Korzenik JR; Sands BE
Gut; 2012 Mar; 61(3):385-91. PubMed ID: 21757451
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and safety of vaccination against seasonal 2012 influenza virus among patients with psoriatic arthritis and psoriasis.
Polachek A; Korobko U; Mader-Balakirski N; Arad U; Levartovsky D; Kaufman I; Anouk M; Litinsky I; Wigler I; Mendelson E; Paran D; Matz H; Caspi D; Mandelboim M; Elkayam O
Clin Exp Rheumatol; 2015; 33(2):181-6. PubMed ID: 25738420
[TBL] [Abstract][Full Text] [Related]
36. Specific antibody response after influenza immunization in systemic lupus erythematosus.
Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
[TBL] [Abstract][Full Text] [Related]
37. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
Holvast A; Huckriede A; Wilschut J; Horst G; De Vries JJ; Benne CA; Kallenberg CG; Bijl M
Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
[TBL] [Abstract][Full Text] [Related]
39. Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients.
Haller W; Buttery J; Laurie K; Beyerle K; Hardikar W; Alex G
Liver Transpl; 2011 Aug; 17(8):914-20. PubMed ID: 21351241
[TBL] [Abstract][Full Text] [Related]
40. Vaccination against influenza in patients with systemic sclerosis.
Litinsky I; Balbir A; Zisman D; Mandelboim M; Mendelson E; Feld J; Braun Y; Anouk M; Kaufman I; Paran D; Caspi D; Elkayam O
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S7-11. PubMed ID: 22409886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
